Skip to content Skip to menu

Medicines are integral to healthcare delivery helping Australians live longer and healthier lives, staying in the workplace, keeping out of hospital and positively contributing to the community and economy.

More

Papers, Reports & Submissions

Publications

Agreements, Indemnity & Compensation Guidelines

Clinical Trials

Awards, Speeches & Media Releases

Media & Events

Member company lounge

Member's Area

Sign up for updates

Sign up for email updates to keep on top of Medicines Australia developments.

CEP Transcript Request

If you would like a transcript for courses completed prior to 2012, please complete the online enquiry form.


Social

#ICYMI PAIG member representative Fiona Sheppard talked all things PAIG at the Mercer Life Sciences Industry Confer… https://t.co/4XOlGxFD02

Proposed Changes to Research and Development Tax Incentive will discourage investment and undermine innovation https://t.co/Uwy07pwplo

Great insight by Pharmaceutical Benefits Advisory Committee member Michelle Burke discussing benefits of gene thera… https://t.co/n80iHyda5Y

The @UN International Day for Tolerance was celebrated on 16 Nov but the importance of #acceptance & #diversity sho… https://t.co/NSxNA3Cm4p

#ICYMI the @FinancialReview discussed #ageism and the lack of organisational recognition older Australians receive.… https://t.co/xEINPsV2Gy

RT @Painaustralia: We @Painaustralia are proud to partner with @ArthritisAust & others including our members @MS_Australia on this project.…

MA calls for novel evaluation systems that capture the value of personalised therapies in our sub to the National A… https://t.co/KzXwFuSZAo

Is backlash good for #inclusion? We heard many insights on resistance to #equality via @DivCouncilAus’… https://t.co/VWgum62Yo0

RT @MTPConnect_AUS: Our Managing Director & CEO @DrDanGrant at @AusBiotech #AusBio19 - “if we get this right, Australia’s part in the globa…

RT @AusBiotech: Paul Cross asks our panelists about the potential of gene therapies, with Prof Alan Trounson, @cartherics , @MonashUni, Dr…

RT @DivCouncilAus: The verdict is in. The audience attending tonight's #DCADebate sponsored by #MLCLifeInsurance found 69% to 31% for the A…

RT @program_bridge: The Bridge Consortium overview - our partners who make this program so vital! ⁦@Amgen⁩ ⁦@AbbVie_AU⁩ ⁦@CSL⁩ ⁦@Macquarie

Innovation is happening in our universities and research institutions, these folks are doing it and they want to pa… https://t.co/G045ZRpFrb

You don't have a product unless you've got the intellectual property. Bill Ketelbey, Actinogen Medical, shares a po… https://t.co/Q9ibplXYHb

From bench to biotech! Dr Anna Lavelle, Chair of Medicines Australia, talks about transforming thought to pharmaceu… https://t.co/fVgwLrFgQe

Top